Ascendis Pharma ADR Logo
DK0060615755
A42ANJ

Ascendis Pharma ADR

Loading quotes...

Forecast

The analysts' average price target is €284.88 (+13.95%). The median is €297.00 (+18.80%).

Buy
  24
Hold
  2
Sell
  0

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Financials

In the last quarter, Ascendis Pharma ADR had revenue of €367.46m and net profit of €73.53m
(EUR) September 2026
YoY
Revenue 367.46m 72.01%
Gross profit 335.16m 75.22%
Net profit 73.53m 220.57%
EBITDA 128.45m 340.76%

Fundamentals

Metric Value
Market capitalization
€16.38bn
Number of shares
65.6m
52-week high/low
€255.87 - €170.56
Dividends No
Beta
0.40
P/E ratio
17.57
PEG ratio
0.03
P/B ratio
10.76
P/S ratio
13.56

Company profile

Name
Ascendis Pharma ADR
CEO
Jan Moller Mikkelsen
Employees 1,189
🍪

Parqet  uses cookies. Learn more